European Companies Search Engine
EU funding (€2,331,285): Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics Hor 1 Jan 2015 EU Research and Innovation programme "Horizon"
Text
Advanced XFEL and Synchrotron based Probes of Protein Structure and Dynamics
This cross-disciplinary Marie Curie Innovative Training Network builds upon the transformative opportunities created by existing X-ray sources and new sources soon to be operative in Europe. These opportunities include using ultrafast X-ray sources to extract time-dependent structural information from proteins; and revolutionary possibilities created by X-ray Free Electron Laser radiation for an entirely new regime of pre-damage serial femtosecond crystallography. No lag should exist between building new sources and training the next generation of scientists well versed in using these facilities. Our research training will yield new scientific insights on fundamental properties of protein structure and dynamics: one of the most challenging problems in structural biology; and technological advancements in diverse fields from pharmacology to nanotechnology. X-probe creates close interdisciplinary collaboration between structural biologists, physical chemists, beamline engineers, software developers, and industrial partners. The rapidly changing state-of-the-art demands that young researchers are trained to meet these new experimental, technical and analysis challenges at the forefront of structural biology and photochemistry. X-probe’s interdisciplinary and intersectorial training network incorporates four leading European X-ray facilities (ESRF, MAXIV Laboratory, European XFEL, SwissFEL); three academic laboratories at the forefront developing X-ray tools to probe protein dynamics; and both large and small industrial partners. Four principal scientists in X-probe are female. X-probe builds close cooperation between traditionally separate fields of research at the very cutting edge of structural biology and creates a visionary training network that would not be possible within any of the individual partner states.
Funded Companies:
| Company name | Funding amount |
| Paul Scherrer Institut | ? |
| Astrazeneca AB | €263,659 |
| Centre National de la Recherche Scientifique CNRS | €262,876 |
| European Synchrotron Radiation Facility | €262,876 |
| Goeteborgs Universitet | €263,659 |
| Lunds Universitet | €263,659 |
| Molirom Srl | €258,061 |
| Universita Degli Studi Di Roma LA Sapienza | €258,061 |
| University OF Hamburg | €249,216 |
| Xtal Concepts GmbH | €249,216 |
Source: https://cordis.europa.eu/project/id/637295
The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Paul Scherrer Institut, Villigen PSI, Switzerland.